BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

WuXi Biologics to Sell $500M Irish Vaccine Facility to Merck & Co. Amid U.S. Legislative Pressures

WuXi Biologics has announced plans to sell its vaccine manufacturing facility in Dundalk, Ireland, to Merck & Co. for approximately $500 million. This ...

January 06, 2025 | News

Sanofi and SK Bioscience Forge Expanded Alliance to Combat Pneumococcal Disease with Next-Gen Vaccines

Pneumococcal disease remains a major global health challenge despite the availability of current vaccines This 21-valent pneumococcal conjugate vaccine ...

December 23, 2024 | News

SK bioscience to Launch Phase 1/2 Trials for First mRNA Vaccine Candidate in Australia

SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2...

December 13, 2024 | News

Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria

The Southern Hemisphere’s only mRNA manufacturing facility has officially opened in Victoria, marking a significant milestone for Australia’s h...

December 11, 2024 | News

Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness

In an exclusive interview with BioPharma APAC, Mr. Brendan O’Callaghan, Executive Vice President, Manufacturing & Supply at Sanofi, sheds light o...

December 09, 2024 | News

Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Approved for Pediatric Use in Hong Kong

Pfizer announced that the Hong Kong Department of Health (DoH) has approved its 20-valent Pneumococcal Conjugate Vaccine (PCV20) for active immunization in...

December 04, 2024 | News

Biogénesis Bagó Strengthens Asian Presence with New Vietnam Office and FMD Vaccine Rollout

After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions, this significant milestone further streng...

December 04, 2024 | News

Vaxxas Expands Global Patent Portfolio to 42, Securing Exclusive Rights to HD-MAP Vaccination Technology

-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...

November 25, 2024 | News

GBI Biomanufacturing Expands Services with Automated Sterile Fill-Finish Capabilities

GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expa...

November 21, 2024 | News

Transgene and NEC Unveil Positive 24-Month Data for TG4050 Cancer Vaccine in Adjuvant Treatment of Head and Neck Cancer at SITC 2024

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Cor...

November 14, 2024 | News

Medidata Introduces Oncology and Vaccine Solutions to Streamline Phase II and III Trials with FDA-Aligned Patient-Centric Design

The new products combine Medidata's diverse technologies and experience from thousands of previous trials to streamline the management of Phase II an...

November 05, 2024 | News

DX&VX Selected for South Korea's ARPA-H Project to Pioneer Room-Temperature mRNA Vaccine Storage

Pioneering Korea's ARPA-H Project: Focused on mRNA Vaccine Room-Temperature Storage and Extra-Long-Term Preservation Creating a Platform for Prolonged R...

November 04, 2024 | News

Clover Biopharmaceuticals' Non-Adjuvanted RSV Vaccine Candidate SCB-1019 Shows Promising Efficacy and Safety in Head-to-Head Comparison with GSK's AREXVY

- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candi...

October 29, 2024 | News

LakeShore Biopharma Gains NMPA Approval for Phase III Trial of Simplified Four-Dose Rabies Vaccine Regimen

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developin...

October 28, 2024 | News

Stay Connected